WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Join the AAN today!
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (55)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, L.
Right arrow Articles by Simon, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, L.
Right arrow Articles by Simon, S. A.

 Previous Article  |  Next Article 

Volume 17, Number 11, Issue of June 1, 1997 pp. 4101-4111
Copyright ©1997 Society for Neuroscience

The Responses of Rat Trigeminal Ganglion Neurons to Capsaicin and Two Nonpungent Vanilloid Receptor Agonists, Olvanil and Glyceryl Nonamide

Received Dec. 20, 1996; revised March 4, 1997; accepted March 24, 1997.

L. Liu1, Y.-C. Lo2, I.-J. Chen1, and S. A. Simon1

1 Departments of Neurobiology and Anesthesiology, Duke University Medical Center, Durham, North Carolina 27710 and 2 Department of Pharmacology, Kaohsiung, Taiwan, 80708 Republic of China

Capsaicin, the pungent ingredient in hot pepper, activates and subsequently desensitizes a subset of polymodal nociceptors. Because its initial application to skin produces pain, nonpungent analogs such as olvanil and glyceryl nonivamide (GLNVA) were synthesized to enhance its clinical use. To explore how these nonpungent analogs differ from capsaicin, whole-cell patch-clamp recordings were performed on cultured rat trigeminal ganglion neurons.

In neurons held at -60 mV, capsaicin, olvanil, and GLNVA were found to activate one or two kinetically distinct inward currents. Two inward currents were also activated when extracellular Ca2+ was replaced with Ba2+ and also when intracellular chloride was replaced by aspartate. The reversal potentials of the rapidly and slowly activating currents were 15.3 ± 6 and -4.0 ± 2.5 mV, respectively. These data provide strong evidence for subtypes of vanilloid receptors. One difference among these agonists is that, on average, the activation kinetics of the currents evoked by 1 µM olvanil and 30 µM GLNVA are considerably slower than those evoked by 1 µM capsaicin. Measurements of the peak current, Ip, versus agonist concentration were fit to the Hill equation to yield values of the half maximal concentrations (K1/2), and the Hill coefficients (n). For capsaicin, olvanil, and GLNVA, K1/2 = 0.68, 0.59, and 27.0 µM; and n = 1.38, 1.32, and 1.24, respectively.

We propose that olvanil and GLNVA are nonpungent because they activate different subtypes of receptors and/or because of their activation kinetics (compared with capsaicin) are, on average, slower than the rate they inhibit action potentials from polymodal nociceptors.

Key words: pain; taste; vanilloid receptors; pungent; olvanil; capsaicin




This article has been cited by other articles:


Home page
J. Neurosci.Home page
A. N. Akopian, N. B. Ruparel, A. Patwardhan, and K. M. Hargreaves
Cannabinoids Desensitize Capsaicin and Mustard Oil Responses in Sensory Neurons via TRPA1 Activation
J. Neurosci., January 30, 2008; 28(5): 1064 - 1075.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y.-C. Lin, H.-W. Uang, R.-J. Lin, I.-J. Chen, and Y.-C. Lo
Neuroprotective Effects of Glyceryl Nonivamide against Microglia-Like Cells and 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Human Dopaminergic Neuroblastoma Cells
J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 877 - 887.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Xu, W. Tian, Y. Fu, T. T. Oyama, S. Anderson, and D. M. Cohen
Functional effects of nonsynonymous polymorphisms in the human TRPV1 gene
Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1865 - F1876.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. N. Akopian, N. B. Ruparel, N. A. Jeske, and K. M. Hargreaves
Transient receptor potential TRPA1 channel desensitization in sensory neurons is agonist dependent and regulated by TRPV1-directed internalization
J. Physiol., August 15, 2007; 583(1): 175 - 193.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. A. Matta, R. L. Miyares, and G. P. Ahern
TRPV1 is a novel target for omega-3 polyunsaturated fatty acids
J. Physiol., January 15, 2007; 578(2): 397 - 411.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. M. Patwardhan, N. A. Jeske, T. J. Price, N. Gamper, A. N. Akopian, and K. M. Hargreaves
The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin
PNAS, July 25, 2006; 103(30): 11393 - 11398.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Lazar, D. C. Braun, A. Toth, Y. Wang, L. V. Pearce, V. A. Pavlyukovets, P. M. Blumberg, S. H. Garfield, S. Wincovitch, H.-K. Choi, et al.
Kinetics of Penetration Influence the Apparent Potency of Vanilloids on TRPV1
Mol. Pharmacol., April 1, 2006; 69(4): 1166 - 1173.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Kim, C. Kang, C. Y. Shin, S. W. Hwang, Y. D. Yang, W. S. Shim, M.-Y. Park, E. Kim, M. Kim, B.-M. Kim, et al.
TRPV1 Recapitulates Native Capsaicin Receptor in Sensory Neurons in Association with Fas-Associated Factor 1
J. Neurosci., March 1, 2006; 26(9): 2403 - 2412.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Wang, A. Toth, R. Tran, T. Szabo, J. D. Welter, P. M. Blumberg, J. Lee, S.-U. Kang, J.-O. Lim, and J. Lee
High-Affinity Partial Agonists of the Vanilloid Receptor
Mol. Pharmacol., August 1, 2003; 64(2): 325 - 333.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Wahl, C. Foged, S. Tullin, and C. Thomsen
Iodo-Resiniferatoxin, a New Potent Vanilloid Receptor Antagonist
Mol. Pharmacol., January 1, 2001; 59(1): 9 - 15.
[Abstract] [Full Text]


Home page
Journal of the American Dental AssociationHome page
M. PADILLA, G. T. CLARK, and R. L. MERRILL
TOPICAL MEDICATIONS FOR OROFACIAL NEUROPATHIC PAIN: A REVIEW
J Am Dent Assoc, February 1, 2000; 131(2): 184 - 195.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
T. Kirschstein, W. Greffrath, D. Busselberg, and R.-D. Treede
Inhibition of Rapid Heat Responses in Nociceptive Primary Sensory Neurons of Rats by Vanilloid Receptor Antagonists
J Neurophysiol, December 1, 1999; 82(6): 2853 - 2860.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Szallasi and P. M. Blumberg
Vanilloid (Capsaicin) Receptors and Mechanisms
Pharmacol. Rev., June 1, 1999; 51(2): 159 - 212.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
E. Carstens, N. Kuenzler, and H. O. Handwerker
Activation of Neurons in Rat Trigeminal Subnucleus Caudalis by Different Irritant Chemicals Applied to Oral or Ocular Mucosa
J Neurophysiol, August 1, 1998; 80(2): 465 - 492.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-